Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: measure (541)

Functional magnetic resonance imaging (MRI) brain scan - patient information

Description: This factsheet explains what a functional magnetic resonance imaging (MRI) brain scan is and what to expect at your appointment.
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Functional-magnetic-resonance-imaging-MRI-brain-scan-4021-PIL.pdf

Nipple and areola micropigmentation - patient information

Description: This factsheet explains what nipple and areola micropigmentation is, what the procedure involves and the benefits and risks.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Nipple-and-areola-micropigmentation-4003-PIL.pdf

AmB-LISOCEL-Cyclophosphamide (300)-Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AmB – LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) Ambulatory Regimen This regimen is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LISOCEL-Cyclophosphamide-300-Fludarabine-30.pdf

BRC Research-imaging-proposal-form_v2 2025 FINAL

Description: BRC Research Imaging Proposal form The BRC Research Imaging Proposal form should be completed by the chief/principal investigator of a
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-Research-imaging-proposal-form-v2-2025-FINAL.docx

AmB - Cytarabine(1500)

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (1500mg/m2) Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use only Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine1500-Ver-1.pdf

2025 WDES report and action plan

Description: Workforce Disability Equality Standard Annual Report 2025 1 Executive Summary The Workforce Disability Equali
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/2025-wdes-report-and-action-plan.pdf

Pain relief at home - patient information

Description: This factsheet explains the different types of pain relief medications you may be prescribed and their common side effects.
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Pain-relief-at-home-2940-PIL.pdf

Finance, Investment and Cash Committee ToR October 2025

Description: Finance, Investment and Cash Committee Terms of Reference Date Issued: Review Date: Document Type: 7 October 2025 Octobe
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Finance-Investment-and-Cash-Committee-ToR-October-2025.pdf

Your steroid medication and emergency card - patient information

Description: This factsheet explains what adrenal insufficiency and adrenal crisis are, the symptoms to look out for and what to do if
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Your-steroid-medication-and-emergency-card-3997-PIL.pdf

AmB - Cytarabine(3000)

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (3000mg/m2) Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use only Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine-3000.pdf

411 to 420 of 639

Previous … 40 41 42 43 44 … Next